NCT03097484View on ClinicalTrials.gov

The Effect of Aromatherapy on Neonatal Abstinence Syndrome and Salivary Cortisol Levels

PHASE3CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

July 25, 2015

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Neonatal Abstinence SyndromeAromatherapy
Interventions
DRUG

lavender and chamomile essential oils

Our patches are obtained from BioEsse Technologies™. Each patch contains a 50:50 mixture of Lavender and Chamomile essential oils in a 55 microliter standard dose patch. The patches release the aromatherapy over a 2-8 hours period and the diffusion rate of each patch is identical. The back of the patch is layered with a hypoallergenic medical grade adhesive, similar to the material found on ECG leads.

Trial Locations (1)

40536

University of Kentucky, Lexington

All Listed Sponsors
lead

John M. Daniel

OTHER

NCT03097484 - The Effect of Aromatherapy on Neonatal Abstinence Syndrome and Salivary Cortisol Levels | Biotech Hunter | Biotech Hunter